tradingkey.logo
tradingkey.logo
Buscar

Lifecore Biomedical Inc

LFCR
Añadir a la lista de seguimiento
5.090USD
-0.180-3.42%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
190.76MCap. mercado
PérdidaP/E TTM

Más Datos de Lifecore Biomedical Inc Compañía

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Información de Lifecore Biomedical Inc

Símbolo de cotizaciónLFCR
Nombre de la empresaLifecore Biomedical Inc
Fecha de salida a bolsaFeb 15, 1996
Director ejecutivoJosephs (Paul)
Número de empleados406
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 15
Dirección3515 Lyman Boulevard
CiudadCHASKA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55318
Teléfono19523684300
Sitio Webhttps://www.lifecore.com/
Símbolo de cotizaciónLFCR
Fecha de salida a bolsaFeb 15, 1996
Director ejecutivoJosephs (Paul)

Ejecutivos de Lifecore Biomedical Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--
Mr. Christopher S. Kiper
Mr. Christopher S. Kiper
Independent Director
Independent Director
25.91K
--
Katrina L. Houde
Katrina L. Houde
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Lifecore Biomedical Inc?

Los cinco principales accionistas de Lifecore Biomedical Inc son: Mr. Paul Josephs

¿Cuántas instituciones poseen acciones de Lifecore Biomedical Inc (LFCR)?

A fecha de 2026Q1, 225 instituciones poseen acciones de Lifecore Biomedical Inc, con un valor de mercado combinado de aproximadamente 30.56M, lo que representa el 81.48% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 1031462.00.

¿Cuál es la mayor fuente de ganancias de Lifecore Biomedical Inc?

El 2026Q1, el segmento empresarial Contract development and manufacturing organization ("CDMO") generó la ganancia más alta para Lifecore Biomedical Inc, ascendiendo a 17.81M y representando el 64.53% de la ganancia total.